This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Institute of Biological Sciences, Beijing. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Qingcui Wu and Circadian Rhythm Innovation.
Introduction
Qingcui Wu is an inventor based in Beijing, China. His patent work includes research into nucleoside analogues and their potential to modulate circadian rhythms.
Latest Patents
Wu is associated with 1 patent, titled “Adenosine Analog and Its Use in Regulating the Circadian Clock.” The invention describes nucleoside analogue compounds and a composition combining a compound with pentostatin. It proposes using these compounds or the composition to modulate circadian rhythms, particularly by shifting circadian phase.
Career Highlights
Wu is associated with the National Institute of Biological Sciences, Beijing. His patent reflects work at the intersection of chemical compounds and biological processes, with a focus on regulating the circadian clock.
Collaborations
The provided information identifies Erquan Zhang and Xiangbing Qi as Wu’s coworkers.
Conclusion
Qingcui Wu’s patent work centers on a nucleoside analogue approach to modulating circadian rhythms and shifting circadian phase.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile